Rejected at 2:36 a.m. Nov, 01, 2023 ] by Ahmed7
Author: levani1999
Related Note: 1488765280375 1
Rationale for change

Changed from FA23,plus sketchy also says that first factor 7 is depleted then C protein
Source: Other - FA23,page 441,3rd line in warfarin adverse effects

Rejection reason

comments

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#AMBOSS::Xz09ri #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::03_Hypercoagulable_States #AK_Step2_v12::#FirstAid::07_Hematology::01_Coagulation_Disorders::01_Normal_Hemostasis #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::09_Vitamin_K_Dependent_Coagulation_Factors #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::02_Warfarin #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::03_Hypercoagulable_States #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki #AK_Step2_v12::#AMBOSS::wx0hAR #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step2_v12::#UWorld::Step::4736 #AK_Step2_v12::#AMBOSS::9x0NAR #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Step1_v12::#AMBOSS::tQaXB4 #AK_Step1_v12::#AMBOSS::M5aMkO #AK_Step2_v12::#UWorld::COMLEX::101516 #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::HemeOnc